Merck begins trial evaluating Zilovertamab Vedotin for previously untreated Diffuse Large B-Cell Lymphoma Ruchika Sharma9 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial...
Merck gets positive EU CHMP opinion for Pneumococcal vaccination in adults Ruchika Sharma2 Feb 2025 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Merck to stop trial evaluating Winrevair early in pulmonary arterial hypertension Ruchika Sharma31 Jan 2025 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating WINREVAIR...
Merck WELIREG gets USFDA priority review for Advanced Pheochromocytoma and Paraganglioma Ruchika Sharma28 Jan 2025 11:15 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck HPV vaccine for men approved in China Ruchika Sharma8 Jan 2025 4:43 PM ISTMerck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration for men aged...
Merck to acquire WuXi Biologics Ireland vaccine facility for USD 500 million Ruchika Sharma8 Jan 2025 10:00 AM ISTChina's WuXi Biologics has announced plans to sell its vaccine facility in Ireland to U.S. pharmaceutical giant Merck & Co. for approximately...
Merck gets UK approval for lung disease drug Sotatercept Ruchika Sharma1 Jan 2025 3:13 PM ISTMerck has received approval from the UK's Medicines and Healthcare products Regulatory Agency for its therapy, sotatercept, to treat a rare lung...
Merck to discontinue bacterial infection drug Zinplava Ruchika Sharma26 Dec 2024 5:44 PM ISTMerck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the U.S. Food and...
Merck closes exclusive global license agreement for LM-299 Ruchika Sharma23 Dec 2024 4:01 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global license agreement for LM-299, a...
Merck, Hansoh Pharma ink pact for oral small molecule GLP-1 receptor agonist Ruchika Sharma20 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have announced that...
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
Merck discontinues clinical development programs for vibostolimab, favezelimab Ruchika Sharma18 Dec 2024 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the clinical development programs for...
